MedTrace Logo

Randomized, Controlled Trial of Regular Sildenafil Citrate in the Prevention of Altitude Illness

NCT00627965 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2008-03-04

No results posted yet for this study

Summary

The purpose of this study is to determine whether regular oral use of sildenafil citrate can prevent or attenuate high altitude illnesses.

Conditions

  • High Altitude Pulmonary Edema
  • Acute Mountain Sickness

Interventions

DRUG

Sildenafil citrate

50mg tds

DRUG

Placebo

Placebo tds

Sponsors & Collaborators

  • University of Edinburgh

    collaborator OTHER

  • Altitude Physiology Expeditions

    lead OTHER

Principal Investigators

  • Matthew Bates · Altitude Physiology Expeditions

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-03-31
Completion
2008-02-29

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00627965 on ClinicalTrials.gov